http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019279900-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 2019-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08c80ea7c201fc1dc140b9562e9e6108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b43bbccdc48576bbf53f58c8ad3fb05
publicationDate 2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2019279900-A1
titleOfInvention Modulators of toll-like receptors for the treatment of HIV
abstract Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR7, including those of Formula 1l: L1 N N.-Z X1(R 3)n Formula || and pharmaceutically acceptable salts thereof, useful in treating HIV infections.
priorityDate 2014-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424223542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465716617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431409283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424223168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126581974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163949050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424223581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424223643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59359830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424223043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428635940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424222991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90136930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59359925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59359793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59359959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59359805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59359938

Total number of triples: 48.